Skip to content
  • My Profile
  • Register
  • Log In
  • Watchlist
AlphaStreet

Market Intelligence Ecosystem

  • News
          • Technology
          • Consumer
          • Health Care
          • Industrials
          • Retail
          • Finance
          • Energy
          • IPO
          • Leisure & Entertainment
          • Research Summary
          • Other Industries
  • News
    • Consumer
    • Energy
    • Finance
    • Health Care
    • Industrials
    • IPO
    • Leisure & Entertainment
    • Other Industries
    • Research Summary
    • Retail
    • Technology
  • AlphaGraphs
  • AlphaStreet Intelligence
  • Log In
  • Register
  • My Profile
  • Watchlist

Categories

  • CEO Insights
  • Fund Manager Insights
  • Concall Highlights
  • Analysis
  • Concall Transcripts
  • AlphaGraphs

Biotech & Pharma

Laurus Labs Ltd Q1FY25; 52% fall in Profits

July 31, 2024July 31, 2024

Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active Pharmaceutical Ingredients

Lupin Ltd Q4FY24; 52% rise in Profits

May 6, 2024May 6, 2024

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations,

Wockhardt Ltd Q2FY24; 11% rise in Revenue

November 14, 2023November 14, 2023

Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams and ointments).

Sanofi India Ltd Q1FY24; 2% rise in Profits

August 10, 2023August 10, 2023

Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Financial Results: Sanofi India Ltd reported Revenues for Q1FY24

Windlas Biotech Ltd Q1FY24; 20% rise in Profits

August 8, 2023August 8, 2023

Windlas Biotech Ltd is a leading domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). The company manufactures both solid and liquid

Supriya Lifescience Ltd (SUPRIYA) Q4 FY23 Earnings Concall Transcript

May 29, 2023June 4, 2023

Supriya Lifescience Ltd (NSE:SUPRIYA) Q4 FY23 Earnings Concall dated May. 29, 2023. Corporate Participants: Irfan Raeen -- Investor Relations Satish Wagh --

Windlas Biotech Limited (WINDLAS) Q4 FY23 Earnings Concall Transcript

May 9, 2023May 9, 2023

Windlas Biotech Limited (NSE:WINDLAS) Q4 FY23 Earnings Concall dated May. 08, 2023. Corporate Participants: Hitesh Windlass -- Managing Director Komal Gupta -- Chief Executive Officer &

Rossari Biotech Ltd (ROSSARI) Q4 FY23 Earnings Concall Transcript

May 3, 2023May 3, 2023

Rossari Biotech Ltd (NSE:ROSSARI) Q4 FY23 Earnings Concall dated May. 02, 2023. Corporate Participants: Aesha Shah -- Investor Relations Edward Menezes -- Executive Chairman & Co-Founder

Laurus Labs Limited Q4FY23 Earnings

April 27, 2023April 27, 2023

To meet the demands of the international pharmaceutical industry, Laurus Labs primarily provides a comprehensive and integrated portfolio of Active Pharmaceutical Ingredients

Laurus Labs Q3FY23 net profit rises by 32 percent

March 1, 2023March 1, 2023

Pharmaceutical and biotechnology company Laurus Labs reported 32% year-on-year (YoY) rise in profit after tax to INR 203 crore for the quarter

Gufic Biosciences Limited (GUFICBIO) Q3 FY23 Earnings Concall Transcript

February 22, 2023February 22, 2023

Gufic Biosciences Limited (NSE:GUFICBIO) Q3 FY23 Earnings Concall dated Feb. 20, 2023. Corporate Participants: Ami Shah -- Company Secretary Avik Das -- Investor Relations D.B.Roonghta -- Chief Financial

Supriya Lifescience Ltd (SUPRIYA) Q3 FY23 Earnings Concall Transcript

February 15, 2023February 15, 2023

Supriya Lifescience Ltd (NSE:SUPRIYA) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Satish Wagh -- Chairman and Managing Director Saloni Wagh -- Director Krishna

Windlas Biotech Limited (WINDLAS) Q3 FY23 Earnings Concall Transcript

February 12, 2023February 12, 2023

Windlas Biotech Limited (NSE:WINDLAS) Q3 FY23 Earnings Concall dated Feb. 09, 2023. Corporate Participants: Hitesh Windlas -- Managing Director Komal Gupta -- Chief Executive Officer and

AMI Organics Ltd (AMIORG) Q3 FY23 Earnings Concall Transcript

February 6, 2023February 6, 2023

AMI Organics Ltd (NSE: AMIORG) Q3 FY23 Earnings Concall dated Feb. 04, 2023 Corporate Participants: Bhavin Shah -- Chief Financial Officer Nareshkumar Patel -- Chief Executive

© 2020 AlphaStreet Inc. All Rights Reserved

Quick Links

  • AlphaGraphs
  • Earnings Transcripts
  • Earnings Calls
  • Contact
  • Company
  • The Team

Contact Info

info@alphastreet.com

44053 Fremont Blvd,
Fremont, CA 94538

Top